Skip to Main content Skip to Navigation
Journal articles

Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-00881032
Contributor : Ed. Bmc Connect in order to contact the contributor
Submitted on : Thursday, November 7, 2013 - 1:04:54 PM
Last modification on : Wednesday, November 10, 2021 - 3:32:02 PM
Long-term archiving on: : Saturday, February 8, 2014 - 7:05:09 AM

Files

Identifiers

  • HAL Id : inserm-00881032, version 1

Collections

Citation

Sandrine Valsesia-Wittmann, Beatrice Clemenceau, Anne-Catherine Jallas, Jean-Yves Blay, Aurelien Marabelle, et al.. Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells. Journal for Immunotherapy of Cancer, BMJ Publishing Group 2013, 1 (Suppl 1), pp.P176. ⟨inserm-00881032⟩

Share

Metrics

Record views

521

Files downloads

569